UNITEDHEALTH GROUP Reports Second Quarter FY2023 Earnings Results on June 30 2023
July 26, 2023
🌥️Earnings Overview
On June 30th, 2023, UNITEDHEALTH GROUP ($NYSE:UNH) reported its second quarter earnings results for FY2023, showing total revenue of USD 91.8 billion, a 14.7% increase compared to the same quarter in the previous year. Net income was USD 5.5 billion, a 7.9% rise year over year.
Market Price
At the market opening, UNITEDHEALTH GROUP stock opened at $462.6 and closed at $480.2. This marked an impressive increase of 7.2% from the previous closing price of 447.8. Analysts have pointed to strong performance in UNITEDHEALTH’s core business segments such as Optum and Unitedhealthcare, as well as strategic acquisitions and cost cutting measures taken by the company as reasons for the favorable results. The positive earnings results have sparked investor optimism and reflected in UNITEDHEALTH shares continuing their upward trend, closing at an all-time high on Friday. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Unitedhealth Group. More…
| Total Revenues | Net Income | Net Margin |
| 345.23k | 21.11k | 5.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Unitedhealth Group. More…
| Operations | Investing | Financing |
| 41.38k | -27.96k | 3.71k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Unitedhealth Group. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 280.16k | 188.01k | 93.84 |
Key Ratios Snapshot
Some of the financial key ratios for Unitedhealth Group are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.9% | 6.2% | 8.8% |
| FCF Margin | ROE | ROA |
| 11.1% | 22.6% | 6.8% |
Analysis
When analyzing UNITEDHEALTH GROUP‘s financials using GoodWhale, it’s easy to see why this company has achieved such strong and stable growth. According to the GoodWhale Star Chart, UNITEDHEALTH GROUP is classified as a ‘gorilla’, reflecting that its competitive advantage has allowed it to capitalize on strong revenue and earning growth. Given its strengths in dividend, growth, profitability, and weak in asset, UNITEDHEALTH GROUP may be attractive to value investors, growth investors, and dividend investors alike. Additionally, UNITEDHEALTH GROUP is quite healthy financially, with a health score of 8/10 according to GoodWhale’s cashflow and debt analysis. This indicates that UNITEDHEALTH GROUP should have no trouble paying off any debt or funding future operations. All things considered, UNITEDHEALTH GROUP appears to be in a strong financial position and could be a solid investment for many types of investor. More…
Peers
One of the largest health insurance providers in the United States is UnitedHealth Group Inc. They offer a wide variety of health insurance plans and are always looking for new ways to provide the best possible service to their customers. Some of their main competitors are Humana Inc, CVS Health Corp, and Centene Corp. Although all of these companies are very different, they all share one common goal: to provide their customers with the best health insurance coverage possible.
– Humana Inc ($NYSE:HUM)
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. As of 2019, Humana has had over 13 million customers in the United States. The company’s revenue was US$54.4 billion in 2018.
– CVS Health Corp ($NYSE:CVS)
CVS Health Corp is a leading provider of healthcare services in the United States. The company has a market capitalization of $120.33 billion as of 2022 and a return on equity of 10.96%. The company operates more than 9,700 retail pharmacies, over 1,100 walk-in medical clinics, and a leading pharmacy benefits manager with more than 77 million members. CVS Health Corp is dedicated to helping people on their path to better health by providing them with the resources they need to make informed decisions about their health and wellbeing.
– Centene Corp ($NYSE:CNC)
Centene Corporation is a large publicly traded managed care organization. The company’s core business is Medicaid managed care, but it also offers Medicare, long-term care, dental, behavioral health, and vision plans. The company serves over 25 million members in 26 states and the District of Columbia.
Centene’s market cap of $43.28 billion and ROE of 6.97% indicate that it is a large and successful company. The company’s size and success are due in part to its focus on Medicaid managed care. Medicaid is a government health insurance program for low-income Americans. Centene has been able to grow its Medicaid business by providing high-quality care at a lower cost than its competitors.
Summary
On June 30 2023, UNITEDHEALTH GROUP reported strong financial results for the second quarter of FY2023 with total revenue of USD 91.8 billion and net income of USD 5.5 billion, representing an increase of 14.7% and 7.9%, respectively, year over year. This prompted a positive sentiment in the market which was reflected in the stock price movement up on the same day. Investors should consider investing in UNITEDHEALTH GROUP as the company boasts strong financials and appears poised for continued growth. The company’s extensive network of medical providers and well-established reputation as a healthcare industry leader make it an attractive option for those looking to invest in a reliable company.
Related Posts
Recent Posts
